Obesity on the Efficacy of Bilateral Tibial Nerve Stimulation
Impact of Obesity on the Efficacy of Bilateral Tibial Nerve Stimulation in Obstructed Defecation
1 other identifier
interventional
60
1 country
1
Brief Summary
Obstructed defecation syndrome (ODS) is a common functional bowel disorder characterized by difficulty in stool evacuation. Bilateral posterior tibial nerve stimulation (BT PTNS) has emerged as a noninvasive, safe, and effective therapeutic option for functional ODS, improving symptom severity and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2025
CompletedFirst Posted
Study publicly available on registry
February 5, 2026
CompletedStudy Start
First participant enrolled
February 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2026
CompletedApril 29, 2026
April 1, 2026
1 month
December 23, 2025
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in symptom severity measured by the Modified Obstructed Defecation Score (MODS).
Scale range: 0 to 24 Interpretation: Higher scores indicate more severe obstructed defecation symptoms Unit of measure: Units on a validated symptom severity scale. No aggregation of different measurements into a single reported value is performed. Each scale is analyzed independently. In response to the Advisory Issue, we have included the unabbreviated titles of the scales, their minimum and maximum values, and clarified whether higher scores represent better or worse outcomes for each outcome measure.
Within 6 weeks of treatment.
Change in quality of life measured by the Patient Assessment of Constipation Quality of Life questionnaire (PAC-QOL).
Scale range: 0 to 96 Interpretation: Higher scores indicate worse constipation-related quality of life Unit of measure: Mean score on a validated quality-of-life scale No aggregation of different measurements into a single reported value is performed. Each scale is analyzed independently. In response to the Advisory Issue, we have included the unabbreviated titles of the scales, their minimum and maximum values, and clarified whether higher scores represent better or worse outcomes for each outcome measure.
Within 6 weeks of treatment.
Secondary Outcomes (1)
Pelvic floor function
Within 6 weeks of treatment.
Study Arms (2)
obese with ODS
ACTIVE COMPARATORBT PTNS in obese patients with ODS
Non obese with ODS
ACTIVE COMPARATORBT PTNS in non-obese patients with ODS
Interventions
* Procedure: BT PTNS will be administered via transcutaneous electrodes placed bilaterally along the posterior tibial nerve at the medial malleolus. * Frequency: 3 sessions per week for 6 weeks (total of 18 sessions). * Duration per Session: 30 minutes. * Monitoring: Patients will be monitored for adverse events during and after each session.
Eligibility Criteria
You may qualify if:
- Diagnosis of functional obstructed defecation (Rome IV criteria).
- Able to provide informed consent.
- BMI ≥30 kg/m² (obese group) or BMI \<30 kg/m² (non-obese group).
You may not qualify if:
- Organic causes of constipation (e.g., colorectal cancer, inflammatory bowel disease).
- Previous pelvic floor surgery.
- Neurological disorders affecting bowel function.
- Pregnancy or lactation.
- Current use of other neuromodulation therapies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The surgical department of Medical Research Institute Hospital, Alexandria University
Alexandria, 21531, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of General surgery
Study Record Dates
First Submitted
December 23, 2025
First Posted
February 5, 2026
Study Start
February 15, 2026
Primary Completion
March 25, 2026
Study Completion
March 28, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04